About
The Oxford Immunology Group (OIG) is a regional branch of the British Society for Immunology (BSI). The aim is to connect students, postdocs, early-career researchers, and faculty with an interest in immunology. Within this group, we host the Science in Progress (SIP) talks once every two months and allow for the exchange of reagents, ideas and techniques across institutes and departments in Oxford.
The Science in Progress (SIP) talks are informal research presentations by graduate students, postdocs, or early career researchers to the Oxford immunology community. The SIP talks will take place once every two months and all are welcome to attend.
*** Graduate students, postdocs, and faculty who wish to give presentations please contact Caitlin O'Brien-Ball ***
SIP talks 2022
When: 21st September, 9.30 am
Where: WTCHG Seminar Room A or online
Dr. Sumana Sharma: Understanding Inhibitory Signalling in T Cells"
Previous talks
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
When: July 27th, 2022, 9:30am
Where: Seminar room at the CAMS China Oxford Institute (COI)/Centre for Cellular and Molecular Physiology (CCMP), The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford, OX3 7BN
***Directions: The best way to find the COI seminar room is by going to the main entrance of the Wellcome Trust Center for Human Genetics, and asking for Ricardo Fernandes at the reception
Registration link: https://bit.ly/3PkVNEd
Sam Palmer (Mathematical Institute): "Why do some diseases increase in risk at the same rate as thymic T-cell production goes down with age?"
Andrew MacLean (Kennedy Institute): "Dynamics of Resident Memory B cell Responses in the Lung"
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
When: June 29th, 2022, 9:30am
Where: Centre for Cellular and Molecular Physiology (CCMP), The Henry Wellcome Building for Molecular Physiology
Registration link: https://bit.ly/399MdEA
Fran Donnellan (Department of Biochemistry): “Generation and characterisation of synergistic broadly neutralising Ebolavirus Glycoprotein monoclonal antibodies”
Isabela Pedroza-Pacheco (Nuffield Department of Medicine): “Understanding the immunological environment associated with development of bnAbs in HIV-1 infection to inform vaccine design”
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
April 27th, 2022
Megan Teh (MRC Human Immunology Unit): “Characterisation of T-cell biochemistry during cellular iron restriction”
Andrew Kwok (Wellcome Centre for Human Genetics): “A neutrophil atlas in sepsis”
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
February 23rd, 2022
Dr. Stephanie Longet (Wellcome Centre for Human Genetics): 'Impact of short or long dosing intervals on humoral and cellular responses to Pfizer/BNT vaccine'
Dr. Daniel O'Connor (Oxford Vaccine Group): 'Utilising the “-omics” toolkit to elucidate the mechanisms underlying immune responses to immunisation and infection'
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
September 3rd, 2020 talks:
Dr. Nick Provine: 'MAIT cell activation augments adenovirus vector vaccine immunogenicity’
Dr. Emma Mead: 'Targeting Neuroinflammation in Alzheimer’s Disease’
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
November 5th, 2020 talks:
Dr. Margarida Rei: 'Enhancing tumour-specific T cell specific responses against glioblastoma'
Dr. Dominik Aschenbrenner: 'Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance'
-------------------------------------------------------------------------------------------------------------------------------------------------------------------
January 21st, 2021 talks:
Ms Lu Li Jovanoska (Dunn School): Innate and adaptive immune modulation by oxidative stress post-translational modifications
Dr. Melanie Dunstan (WTCHG/TGU): Single Cell Profiling of Blood and Gut Cells in Patients with Coeliac Disease and Coeliac Disease + Type 1 Diabetes
 |
Caitlin O’Brien-Ball, CHAIRAfter graduating with a degree in Biomedical Sciences from Queen Mary, University of London, Caitlin moved to Oxford to start her 4 year DPhil at the Radcliffe Department of Medicine, supervised by Prof. Simon Davis and Dr. Mafalda Santos. Caitlin's studies in the Davis Lab are focussed on the regulation and mechanisms of T cell receptor triggering, including the role of cell topology and signalling microclusters. Additionally, in collaboration with the Klenerman group at the University of Cambridge, she is involved in work using super-resolution microscopy to investigate how our current understanding of T cell receptor triggering may apply to other lymphocyte receptors. Throughout her time in Oxford she has had an active role in many committees, as she enjoys giving back to her local community of students and scientists. |
 |
May Sin Ke, SecretaryMay graduated from University of Tsukuba, Japan in 2019 with a BSc in Bio-Resource where she worked under the supervision of Prof. Hiroko Isoda on developing 3D spheriod culture model of primary dermal papilla cell lines to study the effects of natural compounds on hair growth. Currently, she is a DPhil Oncology candidate from the University of Oxford, UK. Tumour heterogeneity is an important factor contributing to cancer immunotherapy resistance. She is interested in studying how tumours can be primed for a better response to the immune checkpoint inhibitors through a combination of biological and computational modelling methods. Her research focuses on investigating the tumour heterogeneity in triple negative breast cancer under acute and chronic hypoxia using methods such as single-cell RNA sequencing and 3D biological models. |
 |
Quang Nguyen, Public Engagement LeadQuang obtained a BS in cell and molecular biology from Duke University, US and an Erasmus LIVE MSc in vaccinology where he interned at GSK Vaccines, BE. Currently, he is an Oxford-Hoffmann DPhil candidate at the University of Oxford, UK. His research integrates high-parameter experimental and computational analyses to identify novel CD8 T cells with immune regulatory functions in human lymphoid tissues. Previously, Quang explored HIV/SIV B cell immunology in the lab of Dr. Sallie Permar at the Duke Human Vaccine Institute, and HIV T cell immunology in the lab of Dr. Richard Koup and Dr. Joseph Casazza at the US NIH Vaccine Research Center. Joining OIG, Quang aims to bring the exciting advances in immunology research within and outside of Oxford to a wider community. |
 |
Carolyn Nielsen, Science in Progress co-LeadCarolyn is a Sir Henry Wellcome Postdoctoral Fellow working with Prof Simon Draper’s Blood-Stage Malaria Group in the Department of Biochemistry. Her research centres on interrogating the impact of vaccine platform and dosing regimen on the cellular drivers of humoral immunity using a combination of flow cytometry, systems serology, and single cell RNA sequencing. Carolyn also runs the upstream single B cell sorting for a variety of mAb production projects and is involved in the Draper group’s controlled human malaria infection (CHMI) model and transfer of this model to colleagues at the Ifakara Health Insititute (Tanzania). Prior to moving to Oxford, Carolyn completed her PhD at the London School of Hygiene and Tropical Medicine under the supervision of Prof Eleanor Riley. Her PhD work, supported by an MRC Vaccine Research studentship, focused on the impact of human cytomegalovirus infection on natural killer cell responses to vaccines. During both her PhD and a prior internship at the World Health Organization, Carolyn has been involved with leading “work-in-progress" programmes similar to the OIG SIP series and is keen to support students and early career researchers develop their networking and presentations skills. |
 |
Ricardo Fernandes, SCIENCE IN PROGRESS CO-LEADRicardo Fernandes recently joined CAMS Oxford Institute coming from Stanford where he developed novel molecules to effectively shut down signalling by immune receptors such as PD-1. |
Please get in touch with us if you would be interested in joining the OIG committee!
We are always looking for new members to join - please spread the word!
Become a Member today
Stay up to date by checking upcoming Science in Progress talks, following us on Twitter, and subscribing to our mailing list!
The OIG members share their reagents and equipment, ideas, protocols, and support, subscribe to participate!
To subscribe to our mailing list, please send an email to sympa@maillist.ox.ac.uk with the following title:
subscribe oig-general (or oig-exchange) Firstname Lastname
For further instruction please check this link: https://web.maillist.ox.ac.uk/ox/help/user#subscribe
For more information please contact Caitlin O'Brien-Ball.